In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.
After finishing at $0.53 in the prior trading day, Century Therapeutics Inc (NASDAQ: IPSC) closed at $0.49, down -7.02%. In other words, the price has decreased by -$7.02 from its previous closing price. On the day, 0.56 million shares were traded. IPSC stock price reached its highest trading level at $0.54 during the session, while it also had its lowest trading level at $0.475.
Ratios:
Our goal is to gain a better understanding of IPSC by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.50. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.30.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 08, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
On August 28, 2023, JP Morgan Downgraded its rating to Neutral which previously was Overweight and also lowered its target price recommendation from $28 to $5.
On December 27, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $19.Chardan Capital Markets initiated its Buy rating on December 27, 2022, with a $19 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 05 ’25 when Farid Adrienne sold 1,024 shares for $0.55 per share. The transaction valued at 563 led to the insider holds 250,693 shares of the business.
Carr Douglas sold 295 shares of IPSC for $162 on May 05 ’25. The SVP Finance & Operations now owns 410,886 shares after completing the transaction at $0.55 per share. On May 05 ’25, another insider, Farid Adrienne, who serves as the Officer of the company, bought 1,024 shares for $0.55 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IPSC now has a Market Capitalization of 42140268 and an Enterprise Value of -93377376. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.39 while its Price-to-Book (P/B) ratio in mrq is 0.26. Its current Enterprise Value per Revenue stands at -14.172 whereas that against EBITDA is 0.766.
Stock Price History:
The Beta on a monthly basis for IPSC is 1.78, which has changed by -0.84376997 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, IPSC has reached a high of $3.47, while it has fallen to a 52-week low of $0.34. The 50-Day Moving Average of the stock is -7.71%, while the 200-Day Moving Average is calculated to be -56.51%.
Shares Statistics:
The stock has traded on average 578.48K shares per day over the past 3-months and 625870 shares per day over the last 10 days, according to various share statistics. A total of 85.84M shares are outstanding, with a floating share count of 38.73M. Insiders hold about 55.05% of the company’s shares, while institutions hold 34.52% stake in the company. Shares short for IPSC as of 1745971200 were 2750001 with a Short Ratio of 4.75, compared to 1743379200 on 3133312. Therefore, it implies a Short% of Shares Outstanding of 2750001 and a Short% of Float of 4.760000000000001.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
